WebCytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based company involved in the R&D and commercialization of medical devices using its proprietary polymer adsorption technology.... WebApr 12, 2024 · A quick review shows that CYTO’s price is currently -7.82% off the SMA20 and -35.92% off the SMA50. The RSI metric on the 14-day chart is currently showing 41.90, and weekly volatility stands at 36.08%. When measured over the past 30 days, the indicator reaches 18.41%. Altamira Therapeutics Ltd. (NASDAQ:CYTO)’s beta value is currently ...
CYTO Altamira Therapeutics Ltd. Stock Price & News - WSJ
WebDec 5, 2024 · FEATURED Fineqia Appoints Independent Trading Group as Market Maker for FNQ on Canadian Securities Exchange • Apr 13, 2024 11:58 AM. FEATURED Tiziana Life Sciences to Pursue Development of Intranasal Foralumab for the Treatment of Long COVID • Apr 13, 2024 7:04 AM. Managing Director/ Sr. Vice President, Smart City/Real … WebCytoSorb ® is a unique blood purification therapy to control deadly inflammation in life-threatening illnesses in the ICU and cardiac surgery. The product is currently approved in … CytoSorbents Corporation and CytoSorbents Medical Inc. 305 College … CytoSorb® is a unique blood purification therapy.The product is currently … B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co … CytoSorbents Corporation (NASDAQ: CTSO) is a U.S. company focused on … Technology is the Beneficiary of ~$39.5M in Government Funding. CytoSorbents’ … Honored with Frost & Sullivan’s Global Product Leadership Award for leading … HemoDefend™ is an extension of CytoSorbents’ powerful bead-based … The ECOS-300CY ™ sorbent cartridge is approved in the European Union for the … optima racing series
CytoSorbents - Overview, News & Competitors ZoomInfo.com
WebTelos Corporation Announces Fourth Quarter Results: Delivers $47.3 Million of Revenue and 38.6% Gross Margin ASHBURN, Va., March 16, 2024 (GLOBE NEWSWIRE) -- … Web1 day ago · Altamira Therapeutics Ltd. (NASDAQ:CYTO) gained 64.8% to $2.1759 after the company reported publication of results from Phase 2 trial with AM-125 in acute vestibular syndrome in leading peer ... portland mi cable providers